Dr. Reddy's gets EIR for formulations manufacturing facility in Andhra Pradesh

23 Oct 2025 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) on October 20, 2025 for its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh, India. 

The United States Food & Drug Administration (USFDA) has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1275.55 -1.45 (-0.11%)
05-Dec-2025 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1807.50
Dr. Reddys Lab 1275.55
Cipla 1525.60
Zydus Lifesciences 933.80
Lupin 2101.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×